Effects of Intravitreal Ranibizumab Injection on Diabetic Macular Edema
DOI:
https://doi.org/10.48047/8w9dse42Keywords:
Diabetic Macular Edema, Intravitreal, Outcome, Single Dose Ranibizumab.Abstract
Background: Diabetic macular edema (DME) is a common complication of diabetes, leading to fluid accumulation in the macula and resulting in vision impairment. With the increasing prevalence of diabetes, DME poses a significant public health challenge. Intravitreal ranibizumab, a VEGF inhibitor, has shown promise in treating DME by reducing retinal vascular permeability and improving visual outcomes.
Downloads
References
Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 1-12. 2. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Prac. 2014;103(2):137-49
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
